Charles River Laboratories
CRL
#1600
Rank
A$19.31 B
Marketcap
A$400.97
Share price
4.38%
Change (1 day)
75.95%
Change (1 year)
Categories

Earnings for Charles River Laboratories (CRL)

Earnings in 2026 (TTM): -A$0.25 Billion

According to Charles River Laboratories 's latest financial reports the company's current earnings are A$4.02 Billion. In 2025 the company made an earning of -A$0.14 Billion a decrease over its 2024 earnings that were of A$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Charles River Laboratories from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.25 Billion73.01%
2025 -A$0.14 Billion-206.86%
2024 A$0.13 B-83.98%
2023 A$0.81 B-6.69%
2022 A$0.87 B29.6%
2021 A$0.67 B7.51%
2020 A$0.62 B47.04%
2019 A$0.42 B7.95%
2018 A$0.39 B-5.14%
2017 A$0.41 B33.21%
2016 A$0.31 B14.07%
2015 A$0.27 B10.04%
2014 A$0.24 B28.39%
2013 A$0.19 B6.61%
2012 A$0.18 B-2.2%
2011 A$0.18 B-140.16%
2010 -A$0.47 Billion-321.56%
2009 A$0.20 B-131.92%
2008 -A$0.66 Billion-314.85%
2007 A$0.30 B23.14%
2006 A$0.24 B10.82%
2005 A$0.22 B4.46%
2004 A$0.21 B15%
2003 A$0.18 B15.93%
2002 A$0.16 B64.66%
2001 A$97.61 M163.31%
2000 A$37.07 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
A$10.42 B-4,586.68%๐Ÿ‡บ๐Ÿ‡ธ USA
SCYNEXIS
SCYX
-A$34.45 Million-85.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A$0.10 B-147.18%๐Ÿ‡บ๐Ÿ‡ธ USA